This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Connecting the dots of undiagnosed autoimmune diseases, together
Early detection allows optimized & cost
effective intervention
Predicta Med offers the first deep learning-based solution for earlydetection and intervention selection of autoimmune diseases
Improve patient outcomes
Reduce cost of care
Lower physician burden
Enhance treatment effectiveness
Empowering primary care
We aggregate data from different sources (EMR/claims).
Predicta Med’s engine enriches the data using our unique dataset and medical logic. Then we analyze the data using a combination of advanced learning techniques and find the correlations to a specific disease. Our platform indicates which patients are at risk and provides actionable insights.
Empowering primary care
Our partners
The primary care physician can engage patients and treat them sooner and more efficiently
Analyzed cases to date:
2.5M
EMR records
84%
avg. accuracy rate
1.7M
claims records
Our predictive platform has been validated for these autoimmune conditions:
Rheumatoid arthritis
Ulcerative colitis
Psoriatic arthritis
Lupus
Multiple sclerosis
Crohn’s
Celiac
Cutting edge deep learning techniques
Domain experts that want to change the world
Predicta Med is led by a team of AI experts, and is working in a collaboration with renowned medical advisors from leading hospitals such as Stanford Medicine, Mayo Clinic, Columbia University, Southwestern and Sheba Hospital.
